Bicara Therapeutics BCAX Common Stock, Shares, Outstanding
Common Stock, Shares, Outstanding at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.
The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bicara Therapeutics's common stock, shares, outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bicara Therapeutics's common stock, shares, outstanding?
- Bicara Therapeutics (BCAX) reported common stock, shares, outstanding of $65.55M in Q1 2026.
- How has Bicara Therapeutics's common stock, shares, outstanding changed year-over-year?
- Bicara Therapeutics's common stock, shares, outstanding increased by 20.2% year-over-year, from $54.53M to $65.55M.
- What is the long-term trend for Bicara Therapeutics's common stock, shares, outstanding?
- Over 2 years (2023 to 2025), Bicara Therapeutics's common stock, shares, outstanding has grown at a 840.1% compound annual growth rate (CAGR), from $640.39K to $56.6M.